Obesity
Why Obesity is so Difficult to Treat
Determination of obesity
Proper definition of obesity
Obesity in perspective of the World Health Organization (WHO)
Historical trends
Health and Economic Costs
Prevalence and Time Trends
Prevalence of obesity among men
Prevalence of obesity among women
Prevalence of obesity among children
Demographic Variations in Overweight and Obesity Prevalence
Economic Costs of Overweight and Obesity (The Evidence Report,1998)
The world market for treating obesity
Causes of obesity
Continuous availability of high-energy foods
a) Imbalance calorie intake and BMR requirements (Gayle M. Galletta)
b) Craze of consumption of unhealthy food
c) Quick life style and less determination of hunger satisfaction
d) Other factors associate with weight gain
Way of eating
Unintentionally over eating
Less planning to make and eat healthy meals (A.D.A.M. Medical Encyclopedia, 2012)
Major reduction in the obligatory need for physical activity (Joseph Proietto, 2011)
a) Spending long hours in front of TVs and computers doing work
b) Relying on cars instead of walking
c) Modern technology and fewer physical demands at home
d) Lack of physical education classes in schools
e) Lack of doing other leisure physical activities.
3. Failed medicinal development for the treatment of obesity
a) Cases of medicinal failure before U.S. Food and Drug Administration (FDA)for treating obesity
i. Wyeth's case of medicinal failure
ii. Sanofi-Aventis case of medicinal failure iii. AU.S. organization's case of medicinal failure
iv. Abbot Company's case of medicinal failure
v. Reductil case of medicinal failure
b) Cases of medicinal failure after U.S. Food and Drug Administration (FDA)for treating obesity
i. Cases of Vivus' Qnexa failure
ii. Cases of Topiramate and Phentermine failure iii. Cases of Contrave failure
iv. Cases of Bupropion failure
c) Aspects of anti-obesity medicinal failure to penetrate into the respective markets
i. First aspect: the awareness of obesity
Role of anti-obesity drugs and their side effects
ii. Second aspect: a unique nature of obesity
Role of traditional obesity treatments and their neurological side effects
d) Outcomes of medicinal development for the treatment of obesity
5-Treatment Guidelines
A. Overview
B. Assessment and Classification of Overweight and Obesity
Assessment of Overweight and Obesity
Classification of Overweight and Obesity
Assessment of Risk Status
Evaluation and Treatment Strategy
Exclusion from Weight Loss Therapy
You’re 80% through this paper. Sign up to read the full paper.
Sign Up Now — Instant Access Already a member? Log inAlways verify citation format against your institution’s current style guide requirements.